In millions, except per share items | Dec-31-21 | Dec-31-20 | Dec-31-19 | Dec-31-18 | Dec-31-17 | Dec-31-16 | Dec-31-15 | Dec-31-14 |
| 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K | 10-K |
Revenues | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Cost of goods sold | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Gross profit | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
Selling, general and administrative [+] | 10.2 | 7.0 | 11.0 | 2.8 | 17.7 | 14.7 | 8.7 | 4.7 |
General and administrative | 10.2 | 7.0 | 11.0 | 2.8 | 17.7 | 14.7 | 8.7 | 4.7 |
Research and development | 11.3 | 7.9 | 6.1 | 0.8 | 34.3 | 24.8 | 17.8 | 8.5 |
Other operating expenses | | | 1.0 | | | | | |
EBITDA [+] | -21.4 | -14.9 | -18.0 | -3.6 | -51.8 | -39.4 | -26.4 | -13.2 |
EBITDA growth | 44.0% | -17.1% | 402.1% | -93.1% | 31.4% | 49.0% | 100.9% | 103.0% |
Depreciation and amortization | 0.0 | 0.0 | 0.1 | 0.1 | 0.2 | 0.1 | 0.1 | 0.0 |
EBIT [+] | -21.4 | -14.9 | -18.1 | -3.6 | -52.0 | -39.5 | -26.5 | -13.2 |
EBIT growth | 43.9% | -17.5% | 395.3% | -93.0% | 31.5% | 49.1% | 100.8% | 103.4% |
Non-recurring items [+] | | | 3.0 | | | | | |
Asset impairment | | | 3.0 | | | | | |
Interest expense, net [+] | 0.0 | -0.1 | -0.3 | 0.0 | 1.5 | 1.0 | 0.8 | 0.2 |
Interest expense | | | 0.0 | 0.0 | 2.2 | 1.2 | 0.8 | 0.2 |
Interest income | 0.0 | 0.1 | 0.4 | | 0.7 | 0.2 | 0.0 | 0.0 |
Other income (expense), net [+] | | | 13.3 | -0.2 | | -0.2 | -1.9 | 0.6 |
Gain (loss) on debt retirement | | | | -0.2 | | | | |
Gain (loss) on acquisitions / transactions | | | 13.3 | | | | | |
Change in fair value of warrants | | | | | | | -1.9 | 0.6 |
Other non-ooperating expenses | | | | 0.0 | | -0.2 | | |
Other | | | | 0.0 | | 0.2 | | |
Pre-tax income | -21.4 | -14.8 | -7.4 | -3.8 | -53.4 | -40.7 | -29.2 | -12.8 |
Income taxes | -4.5 | 0.0 | -0.4 | 0.0 | -2.6 | -1.8 | -1.1 | -0.6 |
Tax rate | 21.1% | 0.0% | 5.2% | 0.0% | 4.8% | 4.5% | 3.8% | 4.6% |
Net income | -16.9 | -14.8 | -7.0 | -3.8 | -50.9 | -38.8 | -32.4 | -13.8 |
|
Basic EPS [+] | ($0.66) | ($0.89) | ($1.44) | ($1.15) | ($1.67) | ($1.34) | ($4.01) | ($8.16) |
Growth | -25.5% | -38.3% | 25.1% | -31.3% | 24.4% | -66.5% | -50.9% | 73.2% |
Diluted EPS [+] | ($0.66) | ($0.89) | ($1.44) | ($1.15) | ($1.67) | ($1.34) | ($4.01) | ($8.16) |
Growth | -25.5% | -38.3% | 25.1% | -31.3% | 24.4% | -66.5% | -50.9% | 73.2% |
|
Shares outstanding (basic) [+] | 25.6 | 16.7 | 4.9 | 3.3 | 30.4 | 28.9 | 8.1 | 1.7 |
Growth | 52.9% | 244.0% | 45.9% | -89.0% | 5.3% | 256.9% | 379.0% | 0.0% |
Shares outstanding (diluted) [+] | 25.6 | 16.7 | 4.9 | 3.3 | 30.4 | 28.9 | 8.1 | 1.7 |
Growth | 52.9% | 244.0% | 45.9% | -89.0% | 5.3% | 256.9% | 379.0% | 0.0% |
|
EBIT is a non-GAAP figure that excludes all non-recurring expenses: restructuring costs, asset impairments, IPR&D writeoffs, and other unusual charges. |